RACK1 and breast carcinoma: With analysis of targeted expression of RACK1 in breast cancer patients with different nodal status, the results showed no significant difference in RACK1 expression between metastatic LN-positive and metastatic LN-negative patients (P=0.0936, Supplementary Figure 6A).